Analyst Calls

MRG analyst Ian Swanson provides a quick analysis of how Medtronic’s new DES will affect the US interventional cardiology market

MRG Principal Analyst Aaron McCracken is back from this year’s ICS and ready to give a comprehensive wrap-up of the most important findings of the conference and the implications for the urology market, particularly focusing on emerging incontinence devices and new clinical evidence.

MRG analyst Ian Swanson discusses the implications of the FDA Advisory Panel’s for the US heart valve market.

On June 15, Cordis announced that it was exiting the global drug-eluting stent (DES) market.

MRG Principal Analyst Karene Dumoulin is back from this year's EuroPCR conference and ready to give a comprehensive wrap-up of some important findings presented at the conference and their implications for the interventional cardiology device market.

MRG analysts Aaron McCracken and Tiffanie Demone are back from this year's AUA and ready to give a comprehensive wrap-up of the most important findings of the conference and their implications for the urology market, particularly focusing on interesting mismatches between clinical evidence, practice patterns, and industry marketing efforts.

MRG analyst Shriram Venkataramana is back from this year’s DDW and ready to give a comprehensive wrap-up of the most important findings of the conference and their implications for the GI Endoscopy and Laparoscopic device markets.

MRG analyst Julie McLaughlin is back from this year’s HRS and ready to give a comprehensive wrap-up of the most important findings of the conference and their implications for the heart rhythm device market, particularly focusing on atrial fibrillation (AF) ablation catheters.

MRG analyst Andrew Lee is back from this year’s SAS and ready to give a comprehensive wrap-up of the most important findings of the conference and their implications for the world spinal market.

MRG analyst Julie McLaughlin is back from this year’s ACC and ready to give a comprehensive wrap-up of the most important findings of the conference and their implications for the US heart valve market.